Flosonics Medical Among Winners of the Vale COVID-19 Challenge
Flosonics Medical is one of the winners of the Vale COVID-19 challenge to help move solutions to market.
OBIO Announces Early Adopter Health Network Call for Applications to Address COVID-19
This is a call to action for companies developing health technologies including COVID-19 management and treatment technologies to be evaluated for commercial readiness within its Early Adopter Health Network
OBIO H2BB Next Term Begins May 27
Limited Spots Available - Contact Us Today! Make OBIO H2BB part of the onboarding you provide new hires and increase employee productivity, development and retention, as well having a competitive edge as you seek top talent.
Lumira Ventures Launches the Double Bottom Line Challenge
Lumira Ventures has launched the Double Bottom Line Challenge to provide funding to community organizations which are supporting groups that have been significantly affected by COVID-19.
Virtual Velocity Fund Pitch Competition
The Velocity Fund Pitch Competition is open for applications. The Fund will invest $50,000 to $100,000 in each of the top four promising, early-stage companies.
Dr. Michael Rudnicki Named a Fellow of The Royal Society
Dr. Michael Rudnicki, Senior Scientist and Program Director, Ottawa Health Research Institute, has been named a Fellow of The Royal Society.
Perimeter Medical Imaging Receives $10.4 Million Grant
Microbix Biosystems Attains Health Canada Establishment Licensing
Microbix Biosystems has attained medical devices establishment licensing from Health Canada, allowing the immediate use of its quality assessment products by clinical laboratories across the country,
Spartan Bioscience Receives Health Canada Approval for Fast, Portable COVID-19 Test
Spartan Bioscience has received approval from Health Canada for its rapid and portable COVID-19 test.
Microbix and Oneworld Create COVID-19 Test Quality Program
Microbix Biosystems Inc. and Oneworld Accuracy have announced a collaboration to provide a global external quality assessment (EQA) program to support clinically-effective COVID-19 testing.
Mobio Interactive Teams Up With Hospitals to Provide COVID-19 Mental Health Support
Mobio Health has announced that it has teamed up with the New York University School of Medicine and the Zurich Psychiatry Hospital to deliver free digital stress-resilience training.
Self Care Catalysts Announces Health Storylines and Collaboration with Roche COVID-19 Data Science Coalition Project
Self Care Catalysts has launched a collaboration with Roche through the Roche COVID-19 Data Science Coalition project. The initiative will use Self Care Catalysts’ Health Storylines as the offiicial COVID-19 app that will collect data from the community.
Zucara Therapeutics Announces US$21 Million Series A Financing
Zucara Therapeutics Inc. has announced that it has closed a US$21 million Series A Financing led by Perceptive Xontogeny Venture Fund.
OBIO's COVID-19 Advocacy Efforts
As the health science industry adjusts to the realities of COVID-19, OBIO continues to advocate and work on your behalf. Over the last two weeks, OBIO has engaged with health science companies in a variety of ways.
OBIO Advocating on Behalf of the Health Science Industry
OBIO sends letter to government with recommendations to expand the federal announced wage subsidy
VBI Vaccines Collaborates with NRC to Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS and MERS
VBI Vaccines has announced a collaboration with the NRC to develop a pan-coronavirus vaccine candidate, targeting COVID-19, SARS, MERS.
Ontario Government Announces Health Science Industry As Essential Business Sector
The Government of Ontario has announced that the health science industry is deemed an essential service in Ontario and will be exempted from temporary closures of businesses due to COVID-19.
Federal Government Announces New Supports for Business in Fight Against COVID-19
Today, the Government of Canada announced a plan to mobilize industry to combat COVID-19. The plan will redirect a variety of streams of government funding toward manufacturing, commercialization and research focused on health science products and services needed during the pandemic.
Federal Government: Economic Response Plan
The Government of Canada has announced a series of measures to help businesses as they respond to COVID-19.
Update from OBIO
Update from the President and CEO - OBIO’s response to COVID-19